Piccart M - Search Results

1

Recurrence dynamics of breast cancer according to baseline body mass index.

Biganzoli E, Desmedt C, Fornili M, de Azambuja E, Cornez N, Ries F, Closon-Dejardin MT, Kerger J, Focan C, Di Leo A, Nogaret JM, Sotiriou C, Piccart M, Demicheli R. Biganzoli E, et al. Among authors: piccart m. Eur J Cancer. 2017 Dec;87:10-20. doi: 10.1016/j.ejca.2017.10.007. Epub 2017 Oct 31. Eur J Cancer. 2017. PMID: 29096156 Clinical Trial.

2

Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancers.

Delvenne CG, Winkler-Gol RA, Piccart MJ, Hustin J, Michaux D, Leclercq G, Nogaret JM, Autier P. Delvenne CG, et al. Among authors: piccart mj. Eur J Cancer. 1992;28(2-3):700-5. doi: 10.1016/s0959-8049(05)80130-3. Eur J Cancer. 1992. PMID: 1350458

3

Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trials.

Piccart MJ, Kerger J, Tomiak E, Perrault DJ. Piccart MJ, et al. Eur J Cancer. 1992;28(2-3):667-72. doi: 10.1016/s0959-8049(05)80122-4. Eur J Cancer. 1992. PMID: 1591090 Review.

4

Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex.

Dodion PF, de Valeriola D, Crespeigne N, Kantrowitz JD, Piccart M, Wery F, Kerger J, Egorin MJ, Forrest A, Bachur NR, et al. Dodion PF, et al. Among authors: piccart m. Ann Oncol. 1991 Sep;2(8):589-96. doi: 10.1093/oxfordjournals.annonc.a058026. Ann Oncol. 1991. PMID: 1793726 Free article. Clinical Trial.

5

Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.

Paridaens R, Focan C, Michel J, Piccart M, Salamon E, Beauduin M, Closon MT, Tueni E, Vindevoghel A, Majois F, et al. Paridaens R, et al. Among authors: piccart m. Cancer Chemother Pharmacol. 1990;26 Suppl:S63-5. doi: 10.1007/BF00685423. Cancer Chemother Pharmacol. 1990. PMID: 2112055

6

Cisplatin combined with carboplatin: a new way of intensification of platinum dose in the treatment of advanced ovarian cancer. Belgian Study Group for Ovarian Carcinoma.

Piccart MJ, Nogaret JM, Marcelis L, Longrée H, Ries F, Kains JP, Gobert P, Domange AM, Sculier JP, Gompel C. Piccart MJ, et al. J Natl Cancer Inst. 1990 Apr 18;82(8):703-7. doi: 10.1093/jnci/82.8.703. J Natl Cancer Inst. 1990. PMID: 2181152

7

Ureteral obstruction in patients with breast cancer.

Recloux P, Weiser M, Piccart M, Sculier JP. Recloux P, et al. Among authors: piccart m. Cancer. 1988 May 1;61(9):1904-7. doi: 10.1002/1097-0142(19880501)61:9<1904::aid-cncr2820610930>3.0.co;2-1. Cancer. 1988. PMID: 3355980

8

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

Tomiak E, Piccart MJ, Kerger J, Lips S, Awada A, de Valeriola D, Ravoet C, Lossignol D, Sculier JP, Auzannet V, et al. Tomiak E, et al. Among authors: piccart mj. J Clin Oncol. 1994 Jul;12(7):1458-67. doi: 10.1200/JCO.1994.12.7.1458. J Clin Oncol. 1994. PMID: 7912725 Clinical Trial.

9

Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future.

Tomiak E, Piccart M. Tomiak E, et al. Among authors: piccart m. Ann Oncol. 1993 Mar;4(3):199-204. doi: 10.1093/oxfordjournals.annonc.a058456. Ann Oncol. 1993. PMID: 8471552 Free article. Review.

10

Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: current status and future prospects.

Piccart MJ, Raymond E, Aapro M, Eisenhauer EA, Cvitkovic E. Piccart MJ, et al. Eur J Cancer. 1995;31A Suppl 7:S1-10. doi: 10.1016/0959-8049(95)00266-l. Eur J Cancer. 1995. PMID: 8562183 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

616 results

Search Page